Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  2,721 results for ""COVID-19 vaccines""

Your Filters

Content Provider : MEDLINE Subject : multiple sclerosis Subject : vaccines
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?

  • Authors : Jeantin L; Department of Neurology, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France.; Abdi B

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2023 Dec 14; Vol. 95 (1), pp. 19-28. Date of Electronic Publication: 2023 Dec 14.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2).

  • Authors : Klineova S; The Corinne Goldsmith Dickinson Center for MS at Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.; Farber RS

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Vaccines*COVID-19 breakthrough infections

  • Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2023 Jul; Vol. 29 (8), pp. 990-1000.Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print Cited Medium: Internet ISSN: 1477-0970

Record details

Read More Add to Saved list
×
Academic Journal

COVID-19 vaccination in people with multiple sclerosis, real-life experience.

  • Authors : Alroughani R; Division of Neurology, Amiri Hospital, Arabian Gulf Street, Sharq 13041, Kuwait; MS Clinic, Ibn Sina Hospital, P.O. Box 25427, Safat 13115, Kuwait. Electronic address: .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; Multiple Sclerosis*

  • Source: Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2022 Sep; Vol. 220, pp. 107374. Date of Electronic Publication: 2022 Jul 19.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine.

  • Authors : Etemadifar M; Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.; Abhari AP

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*SARS-CoV-2 variants

  • Source: Journal of the neurological sciences [J Neurol Sci] 2023 Jan 15; Vol. 444, pp. 120518. Date of Electronic Publication: 2022 Dec 09.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375403 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Serology results after COVID vaccine in multiple sclerosis patients treated with fingolimod.

  • Authors : Ciccone A; Service de Neurologie, CHRU-Nancy, Université de Lorraine, 54000 Nancy, France.; Mathey G

Subjects: Multiple Sclerosis* ; COVID-19* ; Vaccines*

  • Source: Revue neurologique [Rev Neurol (Paris)] 2023 Mar; Vol. 179 (3), pp. 223-229. Date of Electronic Publication: 2022 Dec 07.Publisher: Masson Country of Publication: France NLM ID: 2984779R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0035-3787

Record details

Read More Add to Saved list
×
Academic Journal

Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab.

  • Authors : Räuber S; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Willison A

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Vaccines*

  • Source: Frontiers in immunology [Front Immunol] 2022 Dec 23; Vol. 13, pp. 1037214. Date of Electronic Publication: 2022 Dec 23 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes.

  • Authors : Holroyd KB; Harvard Medical School, Boston, MA, United States; Brigham Multiple Sclerosis Center & Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/complications ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy COVID-19 breakthrough infections

  • Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Nov; Vol. 67, pp. 104079. Date of Electronic Publication: 2022 Jul 28.Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

COVID-19 infection and vaccination against COVID-19: Impact on managing demyelinating CNS disorders in Southern India- experience from a demyelinating disease registry.

  • Authors : Pandit L; Center for Advanced Neurological Research, KS Hegde Medical Academy, Nitte University, Mangalore, India. Electronic address: .; Sudhir A

Subjects: Aquaporins* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Oct; Vol. 66, pp. 104033. Date of Electronic Publication: 2022 Jul 05.Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].

  • Authors : Monschein T; Universitätsklinik für Neurologie, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich. .; Zrzavy T

Subjects: COVID-19* ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/epidemiology ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/prevention & control

  • Source: Der Nervenarzt [Nervenarzt] 2021 Dec; Vol. 92 (12), pp. 1283-1292. Date of Electronic Publication: 2021 Jul 07.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0400773 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed.

  • Authors : Naser Moghadasi A; Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: .

Subjects: COVID-19* ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Vaccines*

  • Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 Nov; Vol. 56, pp. 103263. Date of Electronic Publication: 2021 Sep 13.Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  2,721 results for ""COVID-19 vaccines""